Bioassay Subject Matter Expert Consulting Services to Support the Development of Biologics
Closed Solicitation Posted
This opportunity was awarded. See its 2 award notices in the notice history.
- Solicitation number
- 75N95022Q00498
- Agency
-
National Institute on Drug Abuse
National Institutes of Health, Department of Health and Human Services
- Responses due
- Set-aside
- No set-aside
Opportunity facts
- NAICS code
- 541690 Other Scientific and Technical Consulting Services
- PSC
- R499 Support- Professional: Other
Notice details come from SAM.gov. Updated .
About this opportunity
This solicitation seeks bioassay subject matter expert consulting services to support the development of biologics for the National Institute of Neurological Disorders and Stroke. Consultants must provide technical recommendations and advice on bioassay development and validation for modalities including monoclonal antibodies, peptide therapeutics, viral vectors, nucleic acids, cell-based therapeutics, and proteins. Preferably, consultants will have expertise in more than one modality. Quotes were due by August 25, 2022 and will be evaluated based on relevant experience, technical approach, and price.
There is no set-aside designation. The primary NAICS code is 541715 and PSC code R425. The solicitation anticipates awarding labor-hour contracts for a one year base period and four one-year options running through September 2025. Consultants will support programs at the National Institutes of Health, with an emphasis on the NIH Blueprint Neurotherapeutics Network Biologics, Ultra-Rare Gene Therapy, and Helping to End Addiction Long-term Pain Therapeutics Development initiatives.
Notice text
2 versions
Update #2 · Latest ·
Amendment 0001 - Q&A posted and response deadline extended to 8/25/2022 at 9 am ET
The National Institute of Neurological Disorders and Stroke (NINDS) has a need for biological therapeutics assay development subject matter expert (SME) consulting services. SME consultants will be required to provide technical recommendations and advice that will support the translational development of novel therapeutics (Biologics) for NIH drug discovery and development programs.
The support included in the resultant contract(s) will cover bioassay development and/or qualification/validation for a variety of biologics, including but not limited to: monoclonal antibodies, peptide therapeutics, viral vector therapeutics (e.g., AAV, lentiviruses, etc.), nucleic acid and cell-based therapeutics, proteins, or other biological therapeutic modalities. Preferably, consultants should have significant expertise supporting assay development for more than one biological therapeutic modality (e.g., monoclonals, peptides, ASOs and viral vectors).
Update #1 ·
The National Institute of Neurological Disorders and Stroke (NINDS) has a need for biological therapeutics assay development subject matter expert (SME) consulting services. SME consultants will be required to provide technical recommendations and advice that will support the translational development of novel therapeutics (Biologics) for NIH drug discovery and development programs.
The support included in the resultant contract(s) will cover bioassay development and/or qualification/validation for a variety of biologics, including but not limited to: monoclonal antibodies, peptide therapeutics, viral vector therapeutics (e.g., AAV, lentiviruses, etc.), nucleic acid and cell-based therapeutics, proteins, or other biological therapeutic modalities. Preferably, consultants should have significant expertise supporting assay development for more than one biological therapeutic modality (e.g., monoclonals, peptides, ASOs and viral vectors).
Files
Notice history
| Notice | Type | Posted |
|---|---|---|
| Bioassay Subject Matter Expert Consulting Services to Support the Development of Biologics | Award Notice | |
| Bioassay Subject Matter Expert Consulting Services to Support the Development of Biologics | Award Notice | |
| This notice | Solicitation |
Similar open opportunities
| Opportunity | Agency | Set-aside | Responses due |
|---|---|---|---|
| 2 Senior Advisors Services for the NINDS Blueprint Neurotherapeutic Network for Small Molecules External Oversight Committee (EOC) Subject Matter Expert (SME) Services | — | Total Small Business |
On GovTribe
Work this opportunity
- Track it in your pipeline
- Find teaming partners
- Similar opportunities
- Ask GovTribe AI about this opportunity